iothalamic acid has been researched along with Dyslipidemia in 1 studies
Iothalamic Acid: A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine (IOTHALAMATE MEGLUMINE) salts.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Approximately 24-40% of patients with type 2 diabetes mellitus (T2DM) develop kidney damage." | 1.43 | Early intensive treatment improves outcomes in patients with glomerular hyperfiltration and type 2 diabetes. ( Bonal, J; Bonet, J; Romero, R; Salinas, I; Sanmartí, A; Torres, F; Troya, MI, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Troya, MI | 1 |
| Bonet, J | 1 |
| Salinas, I | 1 |
| Torres, F | 1 |
| Bonal, J | 1 |
| Sanmartí, A | 1 |
| Romero, R | 1 |
1 other study available for iothalamic acid and Dyslipidemia
| Article | Year |
|---|---|
Early intensive treatment improves outcomes in patients with glomerular hyperfiltration and type 2 diabetes.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Cardiovascular Disease | 2016 |